The therapeutic potential of peptides

February 10, 2021

"Insulin is a prime example for a successful peptide drug that has been essential for the health of millions of diabetic patients in the past 100 years," says Markus Muttenthaler, who leads research groups at the Institute of Biological Chemistry of the Faculty of Chemistry at University in Vienna as well as at the Institute for Molecular Bioscience, at the University of Queensland in Brisbane.

Worldwide, peptide therapeutics account for 5% of the global pharmaceutical market, with global sales exceeding US$ 50 billion. More than 150 peptides are in clinical development and another 400-600 peptides undergoing preclinical studies.

Peptide drugs have a distinct space in the pharmaceutical landscape. They are smaller than small molecule drugs, which hold the largest share of therapeutics on the market, and larger than genetically produced biologics such as antibodies. Compared to small molecules, peptides are often more potent and selective, and thus have fewer side effects; compared to antibodies, their production is more economic and they have certain advantages in cancer research, e.g. they can penetrate (tumour) tissue more easily. However, 90% of peptide drugs need to be injected, since the digestive system breaks them down rapidly when taken orally.

Vast peptide libraries

According to the corresponding authors, Assoc. Prof. Markus Muttenthaler and his Australian colleague, Prof. Paul F. Alewood, the increased interest in peptide drugs demands "efficient strategies for the discovery of therapeutic leads". A key trend in peptide drug discovery is the establishment and directed evolution of vast peptide libraries based on latest display technologies, a concept that has been recognised with the Nobel Prize in Chemistry in 2018.

The systematic exploration of animal venoms is another key trend that drives peptide drug discovery, and "allows us to take advantage of the vast natural and over millions of years evolutionary-selected peptide libraries for therapeutic lead discovery", says Muttenthaler, who is very active in this space.

New insights

In a recent study, Muttenthaler's team chemically conjugated a spider-venom peptide with a scorpion-venom peptide. Both substances use different mechanisms to block an ion channel that plays an important role in pain signalling. "Linking the two different binding mechanisms resulted in irreversible blockage of the ion channel, and the concept might be useful for prolonged pain relief," says Muttenthaler.

In a second study, his team, together with Christophe Duplais' group in French Guyana, analysed the venom of the Brazilian ant species, Pseudomyrmex penetrator, and synthesised and characterised the most active component. The potent paralytic effect of the isolated venom peptide against plant pests could serve as a promising lead for environmentally friendly and less hazardous biopesticides.

Identifying the right space within the drug landscape

Peptides are signalling molecules of life that control many physiological functions: "When investigating natural products and complex antibiotics such as vancomycin, it can often take years to establish a chemical synthesis; newly discovered peptide compounds, however, can be synthesised in days, which greatly accelerates the research and development of new peptide therapeutics", Muttenthaler explains. "It is however crucial to identify the right pharmacological space where your peptide drug can outperform small molecule drugs or biologics."
-end-
Publication in Nature Reviews Drug Discovery:
Trends in peptide drug discovery, by Markus Muttenthaler, Glenn F. King, David J. Adams, and Paul F. Alewood, in: Nature Reviews Drug Discovery 2021,
DOI:10.1038/s41573-020-00135-8

University of Vienna

Related Peptides Articles from Brightsurf:

Peptides+antibiotic combination may result in a more effective treatment for leishmaniasis
A combination of peptides and antibiotics could be key to eliminating the parasite causing leishmaniasis and avoiding the toxicity to people and animals caused by current drugs.

Designer peptides show potential for blocking viruses, encourage future study
Chemically engineered peptides, designed and developed by a team of researchers at Rensselaer Polytechnic Institute, could prove valuable in the battle against some of the most persistent human health challenges.

Tracking down cryptic peptides
Using a newly developed method, researchers from the University of Würzburg, in cooperation with the University Hospital of Würzburg, were able to identify thousands of special peptides on the surface of cells for the first time.

Synthesis of prebiotic peptides gives clues to the origin of life on Earth
Coordination Compounds Lab of Kazan Federal University started researching prebiotic peptide synthesis in 2013 with the use of the ASIA-330 flow chemistry system.

Peptides that can be taken as a pill
Peptides represent a billion-dollar market in the pharmaceutical industry, but they can generally only be taken as injections to avoid degradation by stomach enzymes.

Harnessing psyllid peptides to fight citrus greening disease
BTI, USDA and UW scientists have identified peptides in the Asian citrus psyllid, an insect that spreads the bacterium that causes citrus greening disease (huanglongbing, HLB).

New technique has potential to protect oranges from citrus greening
Citrus greening, also called Huanglongbing (HLB), is devastating the citrus industry.

Researchers show what drives a novel, ordered assembly of alternating peptides
A team of researchers has verified that it is possible to engineer two-layered nanofibers consisting of an ordered row of alternating peptides, and has also determined what makes these peptides automatically assemble into this pattern.

Origin of life insight: peptides can form without amino acids
Peptides, one of the fundamental building blocks of life, can be formed from the primitive precursors of amino acids under conditions similar to those expected on the primordial Earth, finds a new UCL study published in Nature.

Ragon Institute study identifies viral peptides critical to natural HIV control
Investigators at the Ragon Institute of MGH, MIT and Harvard have used a novel approach to identify specific amino acids in the protein structure of HIV that appear critical to the ability of the virus to function and replicate.

Read More: Peptides News and Peptides Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.